Innoveren Scientific Inc. (IVRN)
OTCMKTS
· Delayed Price · Currency is USD
0.0004
-0.0003 (-42.86%)
At close: Jan 14, 2026
Innoveren Scientific Revenue
In the year 2022, Innoveren Scientific had annual revenue of $453.46K, down -71.86%.
Revenue
453.46K
Revenue Growth
-71.86%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
3.20K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 453.46K | -1.16M | -71.86% |
| Dec 31, 2021 | 1.61M | -539.15K | -25.07% |
| Dec 31, 2020 | 2.15M | -6.20M | -74.23% |
| Dec 31, 2019 | 8.35M | 463.74K | 5.88% |
| Dec 31, 2018 | 7.88M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hemagen Diagnostics | 4.04M |
| Comera Life Sciences Holdings | 1.00M |
| Entia Biosciences | 265.47K |
| MetaStat | 23.30K |
| ONE Bio | 53.91M |
| Kaleido Biosciences | 1.10M |
Innoveren Scientific News
- 2 years ago - Innoveren Scientific Announces 510(k) Submission for SkinDisc(TM) Lite - Accesswire
- 2 years ago - Innoveren Scientific Divests Device & Receives Capital Infusion - Accesswire